eGain to Announce Fiscal 2020 Third Quarter Financial Results on May 7, 2020
SUNNYVALE, Calif., April 28, 2020 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading provider of omnichannel customer engagement solutions, will announce […]
Amerant Bancorp Inc. Reports First Quarter Results and Provides Business Update Impact From COVID-19 Pandemic
CORAL GABLES, Fla., April 28, 2020 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) […]
Immuron Board Relinquish Cash Payment of Fees
MELBOURNE, Australia, April 28, 2020 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on […]
Dime Community Bancshares, Inc. Increases Quarterly Earnings Per Share by 26% And Grows Net Interest Margin by 12 Basis Points on a Linked Quarter Basis
BROOKLYN, N.Y., April 28, 2020 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime” or “its”), […]
Provident Financial Holdings Reports Third Quarter of Fiscal 2020 Results
Company Reports $1.14 Million of Net Income in the March 2020 Quarter in Comparison to the $151,000 Net Loss in […]
Ragnarok Origin (Mobile) Available for Pre-Registration and CBT in Korea and Ragnarok Online (PC) CBT in Thailand
Seoul, April 28, 2020 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of […]
Yandex Announces First Quarter 2020 Financial Results
MOSCOW and AMSTERDAM, the Netherlands, April 28, 2020 (GLOBE NEWSWIRE) — Yandex (NASDAQ and MOEX: YNDX), one of Europe’s largest […]
Global Security Leaders Outline Four Key Trends for How to Transform a SOC
LEXINGTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) — Mimecast Limited (NASDAQ: MIME), a leading email and data security company, today […]
First-of-Its-Kind Industry Survey Identifies the Digital Experience Wants and Needs of App Dev, Web and Business Leaders Worldwide
900+ decision makers understand the imperatives of digital experience, yet the majority have cancelled or postponed projects; Progress identifies those […]
First patient dosed in avdoralimab Phase II clinical trial in COVID-19 patients with severe pneumonia
Initial translational analysis, EXPLORE, showed overexpression of C5a/C5aR pathway in patients with severe COVID-19Innate Pharma SA (Euronext Paris: IPH – […]
